Reshma P. Shetty, See remarks at Ginkgo Bioworks Holdings, Inc. (DNA), sold 150,600 shares at $2.28 ($358K) on 2023-07-20, disclosed to the SEC on 2023-07-21.
Scheduled sale ($358k) by See remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.47 | 37,650 | $93K | 26.0% |
| 2 | $2.47 | 37,650 | $93K | 26.0% |
| 3 | $2.28 | 37,650 | $86K | 24.0% |
| 4 | $2.28 | 37,650 | $86K | 24.0% |
| Total | $2.38 avg | 150,600 | $358K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |